Statistics
Publications
37
Citations
4.9K
H-Index
25
Active since
1997
Scott W. Andersen is an author at Eli Lilly (United States) specializing in medicine, dementia, and pharmacotherapy.
Publications per year
1997–2025
37
37
Donanemab in Early Alzheimer’s Disease
Mark A. Mintun, Albert Lo, Cynthia Evans et al. · New England Journal of Medicine · 2021 · 1.7K citations · Full text
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease
Stephen Salloway, Martin R. Farlow, Eric McDade et al. · Nature Medicine · 2021 · 365 citations · Full text
Medicine, Neurology, Pharmacotherapy +12
1–5 of 37